Posted 26th April 2017 by Jane Williams
In the last decade, digital pathology has rapidly expanded to become an essential technology tool to support medical education, tissue based research, drug development, and the practise of clinical pathology.
Posted 24th April 2017 by Laura Berry
The 4th Microbiome R&D and Business Collaboration Forum: Europe explored microbiota both inside and outside the gut and examined the role of the human microbiome in various diseases with a focus on modulation and biotherapeutic translation.
Duc H. Le, UK Editor-in-Chief of EBioMedicine, summarises some of the presentations that took place on day one.
Posted 21st April 2017 by Fabio Caligaris
Peter Rådström’s research is about the developments of pre-PCR processing, a method which aims to generate PCR-compatible samples. Diagnostic PCR is often limited by components that interfere with the amplification of PCR inhibitors and pre-PCR can overcome PCR inhibition without impairing the detection limit, addressing all steps leading to PCR amplification, samples treatment and PCR chemistry. This lowers the need for pure extracts, leading to simplified analysis processes and improved detection limits.
Posted 19th April 2017 by Laura Berry
Over the last decade, there has been a huge shift in the popular perception of microorganisms – instead of considering them as potentially pathogenic organisms that should be destroyed, we now realise that the microorganisms living in and on us are an essential part of us and necessary for good health.
Posted 17th April 2017 by Jane Williams
Glenn Walker, Associate Professor at North Carolina State University, is working with colleagues in the Department of Biomedical Engineering to develop low-cost, disposable pumps that can power a wide range of microfluidic devices. The pumps are made by laminating shaped pieces of commercially available filter paper, so they are inexpensive and easily fabricated by just about anyone.
Posted 14th April 2017 by Fabio Caligaris
Host residual DNA (hrDNA) as an impurity in biologic drugs is currently quantified by DNA extraction followed by qPCR. Musaddeq Hussain developed a method for direct qPCR without using DNA extraction from mAb drugs. He gave us his view about the research and challenges of working in the field.
Posted 13th April 2017 by Jane Williams
It has just been announced that the FDA has taken the long awaited step in the move towards wider use of digital pathology. Philips has received permission to market their IntelliSite Pathology Solution for primary diagnostic use in the United States. Is this the first step towards full acceptance of this technology as a front line diagnostic tool?
Posted 12th April 2017 by Jane Williams
In the past decade, microfluidics has emerged as a distinct new field with the potential to influence subjects from chemical synthesis and biological analysis to optics and information technology.